Predicting the Clinical Relevance of Drug Interactions From Pre-Approval Studies

ISSN： 0114-5916

Source： Drug Safety, Vol.32, Iss.11, 2009-11, pp. : 1017-1039

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reporting of Deaths During Pre-Approval Clinical Trials for Advanced HIV-Infected Populations

By Johann-Liang Rosemary James Andrea N. Behr Virginia L. Struble Kimberly Birnkrant Debra B.

Drug Safety, Vol. 28, Iss. 7, 2005-01 ,pp. : 559-564

Adis International

Access to resources Recommend Favorite

Clinical Relevance of Drug-Drug Interactions: A Structured Assessment Procedure

By van Roon Eric N.

Drug Safety, Vol. 28, Iss. 12, 2005-01 ,pp. : 1131-1139

Adis International

Access to resources Recommend Favorite

Pantoprazole: from drug metabolism to clinical relevance

By Bardou Marc Martin Janet

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 4, 2008-04 ,pp. : 471-483

Informa Healthcare

Access to resources Recommend Favorite

Drug Interactions with Grapefruit Juice: Extent, Probable Mechanism and Clinical Relevance

By Fuhr U.

Drug Safety, Vol. 18, Iss. 4, 1998-04 ,pp. : 251-272

Adis International

Access to resources Recommend Favorite

Frequency and Clinical Relevance of Drug Interactions with Lovastatin and Simvastatin: An Observational Database Study

By Tirkkonen Tuire Ryynänen Anna

Drug Safety, Vol. 31, Iss. 3, 2008-01 ,pp. : 231-240

Adis International

Access to resources Recommend Favorite